What's in Serenity Pharmaceuticals, Inc.'s pipeline?

Serenity Pharmaceuticals, Inc. has 5 drugs in our index: 0 marketed, 0 filed, 5 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Serenity Pharmaceuticals, Inc.'s portfolio?

Top competitors by shared drug class: AL-S Pharma, Addpharma Inc., Organon and Co, Tris Pharma, Inc., University Hospital, Strasbourg, France.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/serenity-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Serenity Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief

Serenity Pharmaceuticals, Inc. pipeline: 0 marketed, 0 filed, 5 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 5 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
SER120 1500 ng	SER120 1500 ng	phase 3
SER120 nasal spray 750 ng/day	SER120 nasal spray 750 ng/day	phase 3	Serotonin receptor agonist	5-HT1A	Psychiatry
SER120 Nasal Spray 500 ng/day	SER120 Nasal Spray 500 ng/day	phase 3
SER120 750 ng	SER120 750 ng	phase 3	Serotonin receptor modulator	5-HT receptor	Psychiatry
SER120	SER120	phase 3	serotonin receptor antagonist	5-HT2A receptor	Psychiatry

Therapeutic area mix

Psychiatry · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AL-S Pharma · 1 shared drug class
Addpharma Inc. · 1 shared drug class
Organon and Co · 1 shared drug class
Tris Pharma, Inc. · 1 shared drug class
University Hospital, Strasbourg, France · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Serenity Pharmaceuticals, Inc.:

Cite this brief

Drug Landscape (2026). Serenity Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/serenity-pharmaceuticals-inc. Accessed 2026-05-16.